| Eurlex法規(guī)編號(hào)： |
2024/1844 |
| OJ編號(hào)： |
OJ L, 2024/1844, 5.7.2024 |
| 中文標(biāo)題： |
2024年6月25日理事會(huì)決議(EU) 2024/1844：代表歐盟在EEA聯(lián)合委員會(huì)內(nèi)就修正附件II（技術(shù)條例、標(biāo)準(zhǔn)、測(cè)試和認(rèn)證）和議定書37（包含EEA協(xié)定第101條規(guī)定的清單）（加強(qiáng)歐洲醫(yī)學(xué)管理局（EMA）在醫(yī)藥產(chǎn)品和醫(yī)療器械危機(jī)準(zhǔn)備和管理中的作用）所采取的立場(chǎng)（內(nèi)容與EEA相關(guān)） |
| 原文標(biāo)題： |
Council Decision (EU) 2024/1844 of 25 June 2024 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning the amendment of Annex II (Technical regulations, standards, testing and certification) and Protocol 37 containing the list provided for in Article 101 to the EEA Agreement (Reinforced role for EMA in crisis preparedness and management for medicinal products and medical devices)Text with EEA relevance. |
| 發(fā)布日期 |
2024-07-05 |
| 原文鏈接 |
查看歐盟官網(wǎng)文件 |
閱讀：63次
粵公網(wǎng)安備 44010602010620號(hào)